Search Results - "Bajenaru, O"

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial by Comi, G, Prof, Martinelli, V, MD, Rodegher, M, MD, Moiola, L, MD, Bajenaru, O, Prof, Carra, A, Prof, Elovaara, I, Prof, Fazekas, F, Prof, Hartung, HP, Prof, Hillert, J, Prof, King, J, MD, Komoly, S, Prof, Lubetzki, C, Prof, Montalban, X, Prof, Myhr, KM, Prof, Ravnborg, M, MD, Rieckmann, P, Prof, Wynn, D, MD, Young, C, Prof, Filippi, M, MD

“…Summary Background Glatiramer acetate, approved for the treatment of relapsing-remitting multiple sclerosis, reduces relapses and disease activity and burden…”
Get full text

Study of the role of vitamin D and insulin resistance in patients with Parkinson’s disease by Bajenaru, O.-L., Ene, A., Ribigan, A., Terecoasa, E., Tiu, C., Bajenaru, O.-A.

Get full text

The metabolic syndrome and dementia by Bajenaru, O

Get full text

How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study by Colosimo, Carlo, Charles, David, Misra, Vijay P., Maisonobe, Pascal, Om, Savary

“…Background Patients with cervical dystonia (CD) typically require regular injections of botulinum toxin to maintain symptomatic control. We aimed to document…”
Get full text

Why antiplatelet treatment in spontaneous internal carotid dissection? by Bajenaru, O., Tiu, C., Dorobat, B., Antochi, F.

“…Spontaneous dissection of the internal carotid artery is a leading cause of stroke and TIA, particularly in young patients. The antithrombotic treatment with…”
Get full text

INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin by Misra, Vijay P., Colosimo, Carlo, Charles, David, Chung, Tae Mo, Maisonobe, Pascal, Om, Savary

“…Background Longitudinal cohort studies provide important information about the clinical effectiveness of an intervention in the routine clinical setting, and…”
Get full text

Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study by Colosimo, Carlo, Charles, David, Misra, Vijay P., Maisonobe, Pascal, Om, Savary

“…The article How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment?…”
Get full text

Low prevalence etiology in a patient with hemispheric stroke by Popescu, D, Mergeani, A, Dorobat, B, Bajenaru, O, Antochi, F

Get full text

Autoimmune epilepsy — Diagnosis, therapeutic remarks and outcome by Mindruta, I, Tiu, C, Antochi, F, Cobzaru, A.M, Coclitu, C, Bajenaru, O

Get full text

The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience by Băjenaru, O., Ene, A., Popescu, B. O., Szász, J. A., Sabău, M., Mureşan, D. F., Perju-Dumbrava, L., Popescu, C. D., Constantinescu, A., Buraga, I., Simu, M.

“…Chronic treatment with oral levodopa is associated with an increased frequency of motor complications in the late stages of Parkinson’s disease (PD)…”
Get full text

Balance assessment using computerized static posturography by Roceanu, Adina, Capris, Georgeta, Bajenaru, Ovidiu Alexandru

“…Equilibrium is a complex process. Combined visual, somatosensory and vestibular inputs are required in order to maintain the body balance. Any dysfunction in…”
Get full text

The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing–remitting multiple sclerosis by De Stefano, N, Filippi, M, Confavreux, C, Vermersch, P, Simu, M, Sindic, C, Hupperts, R, Bajenaru, O, Edan, G, Grimaldi, L, Marginean, I, Medaer, R, Orefice, G, Pascu, I, Pelletier, J, Sanders, E, Scarpini, E, Mancardi, GL

“…Objective Two pilot studies were conducted to evaluate safety, tolerability, and efficacy of two doses of Protiramer (TV-5010) in patients with…”
Get full text

Imaging brain networks - short presentation of new techniques by Roceanu, Adina, Onu, Mihaela, Badea, Liviu, Bajenaru, Ovidiu

“…The brain is organized into large-scale functional networks with interactions between them. For the purpose of imaging brain networks, two fMRI techniques are…”
Get full text

Effects and tolerability of betahistine in patients with vestibular vertigo: results from the Romanian contingent of the OSVaLD study by Băjenaru, Ovidiu, Roceanu, Adina Maria, Albu, Silviu, Zainea, Viorel, Pascu, Alexandru, Georgescu, Mădălina Gabriela, Cozma, Sebastian, Mărceanu, Luigi, Mureşanu, Dafin Fior

“…An efficacy population of 245 patients with vertigo of peripheral vestibular origin was recruited in Romania as part of a 3-month multinational, post-marketing…”
Get full text

Dantrolene protects neurons against kainic acid induced apoptosis in vitro and in vivo by Popescu, B. O., Oprica, M., Sajin, Maria, Stanciu, Cristina L., Bajenaru, O., Predescu, Andreea, Vidulescu, Cristina, Popescu, L. M.

“…Apoptotic cell death induced by kainic acid (KA) in cultures of rat cerebellar granule cells (CGC) and in different brain regions of Wistar rat pups on…”
Get full text

Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke by Bajenaru, O, Tiu, C, Moessler, H, Antochi, F, Muresanu, D, Popescu, B O, Novak, Philipp

“…The purpose of the study was to investigate the efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke. The primary objective of this trial…”
Get full text

Electroencephalographic evaluation in patients with impaired consciousness by Roceanu, Adina, Mindruta, Ioana, Ene, Amalia, Copaciu, Elena, Bajenaru, Ovidiu Lucian, Bajenaru, Ovidiu Alexandru, Tiu, Cristina

“…The electroencephalographic examination (EEG) records spontaneous electrical activity generated in the cerebral cortex. The EEG is abnormal in almost all…”
Get full text

Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations by Borgohain, Rupam, Szasz, J., Stanzione, P., Meshram, C., Bhatt, M., Chirilineau, D., Stocchi, F., Lucini, V., Giuliani, R., Forrest, E., Rice, P., Anand, R.

“…ABSTRACT Levodopa is effective for the motor symptoms of Parkinson's disease (PD), but is associated with motor fluctuations and dyskinesia. Many patients…”
Get full text

Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease by Borgohain, Rupam, Szasz, Jozsef, Stanzione, Paolo, Meshram, Chandrashekhar, Bhatt, Mohit H., Chirilineau, Dana, Stocchi, Fabrizio, Lucini, Valentina, Giuliani, Rodolfo, Forrest, Emma, Rice, Patricia, Anand, Ravi

“…In a 6‐month double‐blind, placebo‐controlled study of Parkinson's disease patients with motor fluctuations, safinamide 50 and 100 mg/d significantly increased…”
Get full text

Investigating motor imagery tasks by their neural effects - A case study by Nicolae, I. E., Stefan, M. M. C., Hurezeanu, B., Taralunga, D. D., Strungaru, R., Vasile, T. M., Bajenaru, O. A., Ungureanu, G. M.

“…Motor imagery, one of the first investigated neural process for Brain-Computer Interfaces (BCIs) still provides a great challenge nowadays. Aiming a better and…”
Get full text